Sort
326,823 grants matching “clinical trial”
The role of senescent cells in dysregulating immune responses and pathogen control
$2,709,110Stephen C Jameson · University Of Minnesota · P01 · FY2025 · AI
The Duke Senescent Cell Evaluations in Normal Tissues (SCENT) Mapping Center
$2,708,925Patty J Lee · Duke University · U54 · FY2021 · AG
Combining Pregabalin with Lofexidine: Can it Increase the Success of Transition to Naltrexone?
$2,708,839Kyle Matthew Kampman · University Of Pennsylvania · UH3 · FY2024 · DA
A Long-Acting Bioabsorbable Naltrexone Subcutaneous Implant for Opioid Use Disorder
$2,708,703Steven M Cohen · Drug Delivery Company, Llc, The · UH3 · FY2025 · DA
Cincinnati Children's Hospital Medical Center Vaccine and Treatment Evaluation Units (UM1 Clinical Trial Required)
$2,708,294Robert Wilson Frenck · Cincinnati Childrens Hosp Med Ctr · UM1 · FY2022 · AI
THE ALLIANCE NCTN BIOREPOSITORY AND BIOSPECIMEN RESOURCE
$2,706,967Mark A Watson · Washington University · U24 · FY2019 · CA
Cross Sectional and Longitudinal Racial Disparity in Molecular Biomarkers of Alzheimer Disease
$2,706,678Chengjie Xiong · Washington University · R01 · FY2022 · AG
PACTTE-Partnership for Anemia: Clinical and Translational Trials in the Elderly
$2,706,562Harvey Jay Cohen · Duke University · U01 · FY2016 · AG
The Pacific Cancer Research Consortium (PCRC), an NCORP Community Site
$2,706,333Charles Drescher · Swedish Medical Center, First Hill · UG1 · FY2025 · CA
Medidata Rave Hosting and Maintenance
$2,706,302Kathi Celii · Westat, Inc. · N02 · FY2016 · CA
HYPERTHERMIA AND PERFUSION EFFECTS IN CANCER THERAPY
$2,705,493Duke University · P01 · FY2001 · CA
Atherosclerosis Intervention with Novel Tissue Selective Estrogen Complex Therapy
$2,705,412Howard N Hodis · University Of Southern California · R01 · FY2020 · AG
StAtins Use in intRacereberal hemorrhage patieNts MRI (SATURN MRI) Ancillary Study
$2,705,364Magdy H Selim · Beth Israel Deaconess Medical Center · UF1 · FY2021 · NS
Pharmacogenetics of Nicotine Addiction Treatment
$2,705,047Caryn Lerman · University Of Pennsylvania · U01 · FY2011 · DA
Treatment for Complex Patients: Continuing and Extended Care
$2,704,682Joseph R Guydish · University Of California, San Francisco · P50 · FY2012 · DA
Therapeutic Targeting of Vascular Subphenotypes of Lung Disease
$2,704,375Mark Thomas Gladwin · University Of Pittsburgh At Pittsburgh · P01 · FY2016 · HL
CTSA INFRASTRUCTURE FOR CLINICAL TRIALS
$2,704,347Ronald J Sokol · University Of Colorado Denver · UL1 · FY2009 · RR
GENERAL CLINICAL RESEARCH CENTER
$2,704,143Thomas F Boat · Cincinnati Childrens Hosp Med Ctr · M01 · FY2006 · RR
SAN DIEGO CLINICAL AND TRANSLATIONAL RESEARCH INSTITUTE
$2,704,012Gary Steven Firestein · University Of California, San Diego · UL1 · FY2011 · RR
Center for Clinical and Translational Sciences (CCTS)
$2,703,945David D McPherson · University Of Texas Hlth Sci Ctr Houston · UL1 · FY2015 · TR
South-seq: DNA sequencing for newborn nurseries in the South
$2,703,443Gregory Michael Cooper · Hudson-Alpha Institute For Biotechnology · U01 · FY2017 · HG
Pediatric Asthma Network Data coordinating Center
$2,703,030David T Mauger · Pennsylvania State Univ Hershey Med Ctr · U10 · FY2008 · HL
NIH TOLL BOX FOR ASSESSMENT OF NEUROLOGICAL AND BEHAVIORAL
$2,703,000Richard Gershon · Endeavor Health Clinical Operations · N01 · FY2009 · AG
UNC MACS/WIHS Combined Cohort Study Clinical Research Site
$2,702,913Michelle Floris-Moore · Univ Of North Carolina Chapel Hill · U01 · FY2024 · HL
Spatiotemporal Tumor Analytics for Guiding Sequential Targeted-Inhibitor: Immunotherapy Combinations (ST-Analytics)
$2,702,613James R. Heath · Institute For Systems Biology · U54 · FY2022 · CA